Articles

Sitagliptin was non-inferior to metformin in improving HbA1c in treatment-naive patients with Type 2 diabetes….

There is growing evidence that periodontitis may affect general health. This study by university researchers from the Netherlands was assigned to explore the robustness of observations that periodontal therapy leads to the improvement of glycemic control in diabetic patients….

One out of every five U.S. teenagers has a cholesterol level that increases the risk of heart disease, federal health officials reported, providing striking new evidence that obesity is making more children prone to illnesses once primarily limited to adults….

Therapy with exenatide plus rosiglitazone offset the weight gain observed with rosiglitazone, and elicited an additive effect on glycemic control, with significant improvements, researchers from the Department of Medicine, University of Texas Health Science Center, San Antonio, TX found in a new study….

Ten-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study.…

Increases in fasting plasma glucose during childhood — even though levels remain in the normal range 85-100mg/dL.) — can predict adult prediabetes and Type 2 diabetes later in life, a retrospective cohort study showed.…

Metformin XR (extended release formulation) appears to cause a decrease in body mass index (BMI) in non-diabetic obese adolescents when combined with a lifestyle intervention program….

Patients with high levels of proteinuria (protein in urine) in addition to another marker of reduced kidney function had an associated increased risk of all-cause death, heart attack or progression to kidney failure, according to a study.

Closed-loop insulin delivery systems can improve overnight blood sugar control and reduce hypoglycemia risk in young patients with Type 1 diabetes, researchers have found….

Metformin reduces insulin-dose requirement in Type 1 diabetes. As adding metformin to insulin therapy has been advocated in Type 1 diabetes, researchers at the Universities of Dundee and Aberdeen, U.K., conducted a systematic review of published clinical trials and clinical trial databases to assess the effects on HbA1c, weight, insulin-dose …